Maxigen Biotech Inc. (TPE:1783)

Taiwan · Delayed Price · Currency is TWD

40.75

-1.00 (-2.40%)

Apr 20, 2026, 1:24 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biomedical Products			644.57M	559.72M	414.87M	313.55M	297.30M
Biomedical Products Growth			15.16%	34.91%	32.32%	5.47%	12.40%
Adjustment and Write-Off			-42.87M	-	-	-	-
Consumable Products			20.41M	44.71M	97.10M	144.14M	154.90M
Consumable Products Growth			-54.34%	-53.95%	-32.63%	-6.95%	-5.07%
Total			622.12M	604.43M	511.98M	457.69M	452.20M
Total Growth			2.93%	18.06%	11.86%	1.21%	5.73%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan			275.62M	245.23M	200.33M	189.68M	178.33M
Taiwan Growth			12.40%	22.41%	5.61%	6.36%	-4.31%
Asia			95.82M	133.54M	90.54M	60.90M	77.16M
Asia Growth			-28.25%	47.50%	48.68%	-21.08%	-19.41%
Others			23.94M	5.89M	15.24M	19.03M	8.52M
Others Growth			306.59%	-61.37%	-19.89%	123.23%	-43.27%
America			198.81M	189.63M	165.01M	147.97M	139.63M
America Growth			4.84%	14.92%	11.52%	5.97%	36.26%
Europe			27.93M	30.15M	40.86M	40.13M	48.55M
Europe Growth			-7.38%	-26.21%	1.82%	-17.35%	72.99%
Total			622.12M	604.43M	511.98M	457.69M	452.20M
Total Growth			2.93%	18.06%	11.86%	1.21%	5.73%

Source: S&P Global Market Intelligence.